03.06.2013 Views

APPENDICES - NIHR Health Technology Assessment Programme

APPENDICES - NIHR Health Technology Assessment Programme

APPENDICES - NIHR Health Technology Assessment Programme

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

DOI: 10.3310/hta14370 <strong>Health</strong> <strong>Technology</strong> <strong>Assessment</strong> 2010; Vol. 14: No. 37<br />

inoperable esophageal and cardial cancers. Recent<br />

Advances in Bronchoesophagology, Proceedings of<br />

the 6th World Congress of Bronchoesophagology,<br />

1990, pp. 191–7.<br />

90. Okunaka T, Kato H, Conaka C, Yamamoto H,<br />

Bonaminio A, Eckhauser ML. Photodynamic<br />

therapy of esophageal carcinoma. Surg Endosc<br />

1990;4:150–3.<br />

91. Okushima N, Muto Y, Kaburagi Y, Muroi M, Ide<br />

H, Suzuki S, et al. [Photodynamic therapy: its<br />

application for the treatment of esophageal cancer.]<br />

Nippon Geka Gakkai Zasshi 1989;90:1594–7.<br />

92. Okushima N, Yoshida M, Muroi M. [Endoscopic<br />

photoradiation therapy for esophageal cancer.]<br />

Gastroenterol Endosc 1985;27:177–83.<br />

93. Orth K, Ruck A, Beck G, Stanescu A, Beger HG.<br />

[Photodynamic therapy of small adenocarcinomas<br />

with methylene blue.] Chirurgie 1995;66:1254–7.<br />

94. Orth K, Ruck A, Stanescu A, Beger HG.<br />

Intraluminal treatment of inoperable oesophageal<br />

tumours by intralesional photodynamic therapy<br />

with methylene blue. Lancet 1995;345:519–20.<br />

95. Orth K, Stanescu A, Ruck A, Russ D, Beger<br />

HG. [Photodynamic ablation and argon-plasma<br />

coagulation of premalignant and early-stage<br />

malignant lesions of the oesophagus: an alternative<br />

to surgery?] Chirurgie 1999;70:431–8.<br />

96. Overholt BF, Panjehpour M. Photodynamic therapy<br />

in Barrett’s esophagus: reduction of specialized<br />

mucosa, ablation of dysplasia, and treatment of<br />

superficial esophageal cancer. Semin Surg Oncol<br />

1995;11:372–6.<br />

97. Overholt BF, Panjehpour M. Barretts esophagus:<br />

photodynamic therapy for ablation of dysplasia,<br />

reduction of specialized mucosa and treatment of<br />

superficial esophageal cancer. SPIE Proceedings Series<br />

1995;2371:375–84.<br />

98. Overholt BF, Panjehpour M. Photodynamic therapy<br />

in Barrett’s esophagus. J Clin Laser Med Surg<br />

1996;14:245–9.<br />

99. Overholt BF, Panjehpour M. Photodynamic therapy<br />

for Barrett’s esophagus: clinical update. Am J<br />

Gastroenterol 1996;91:1719–23.<br />

100. Overholt BF, Panjehpour M, Ayres M.<br />

Photodynamic therapy for Barrett’s esophagus:<br />

cardiac effects. Lasers Surg Med 1997;21:317–20.<br />

101. Overholt BF, Panjehpour M, Halberg DL.<br />

Photodynamic therapy for Barrett’s esophagus with<br />

dysplasia and/or early stage carcinoma: long-term<br />

results. Gastrointest Endosc 2003;58:183–8.<br />

© 2010 Queen’s Printer and Controller of HMSO. All rights reserved.<br />

102. Overholt BF, Panjehpour M, Haydek JM.<br />

Photodynamic therapy for Barrett’s esophagus:<br />

follow-up in 100 patients. Gastrointest Endosc<br />

1999;49:1–7.<br />

103. Overholt BF, Panjehpour M, Teffetellar E, Rose M.<br />

Photodynamic therapy (PDT) utilizing photofrin<br />

for treatment of early esophageal cancer. SPIE<br />

Proceedings Series 1993;1881:35–40.<br />

104. Pan LN, Zhang ZY, Li M, Su RL. [Effect of<br />

photodynamic therapy for esophageal carcinoma in<br />

near future.] World Chin J Digestol 2006;14:530–2.<br />

105. Panjehpour M, Overholt BF, Haydek JM, Dougherty<br />

TJ. Photodynamic therapy with photofrin followed<br />

by thermal ablation for elimination of dysplasia and<br />

early cancer in Barrett’s esophagus: follow-up in 100<br />

patients. SPIE Proceedings Series 1998;3247:14–24.<br />

106. Patrice T, Foultier MT, Yactayo S, Adam F, Galmiche<br />

JP, Douet MC, et al. Endoscopic photodynamic<br />

therapy with hematoporphyrin derivative for<br />

primary treatment of gastrointestinal neoplasms<br />

in inoperable patients. Digestive Diseases & Sciences<br />

1990;35:545–52.<br />

107. Patrice T, Foultier MT, Yactayo S, Douet MC,<br />

Maloisel F, Le Bodic L. Endoscopic photodynamic<br />

therapy with haematoporphyrin derivative<br />

in gastroenterology. J Photochem Photobiol B<br />

1990;6:157–65.<br />

108. Pazurek M, Malecka-Panas E. Photodynamic<br />

therapy in the palliative treatment of esophageal<br />

cancer. Photodiag Photodyn Ther 2005;2:73–7.<br />

109. Peters F, Kara M, Rosmolen W, Aalders M, Ten<br />

Kate F, Krishnadath K, et al. Poor results of<br />

5-aminolevulinic acid-photodynamic therapy for<br />

residual high-grade dysplasia and early cancer<br />

in barrett esophagus after endoscopic resection.<br />

Endoscopy 2005;37:418–24.<br />

110. Privalov VA, Lappa AV, Seliverstov OV,<br />

Faizrakhmanov AB, Yarovoy NN, Kochneva EV, et<br />

al. Clinical trials of a new chlorin photosensitizer<br />

for photodynamic therapy of malignant tumors.<br />

Optical Methods for Tumor Treatment and Detection:<br />

Mechanisms and Techniques in Photodynamic Therapy XI<br />

2002;4612:178–89.<br />

111. Radu A, Grosjean P, Fontolliet C, Wagnieres G,<br />

Woodtli A, Bergh HV, et al. Photodynamic therapy<br />

for 101 early cancers of the upper aerodigestive<br />

tract, the esophagus, and the bronchi: a singleinstitution<br />

experience. Diagn Ther Endosc<br />

1999;5:145–54.<br />

112. Rahmani EY, Rex DK, Ciaccia D, Turpin CS.<br />

Photodynamic therapy for ablation of esophageal<br />

161

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!